Astrana Health, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Astrana Health, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Astrana Health, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $30.1M, a 11.2% increase year-over-year.
  • Astrana Health, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $95.4M, a 14.9% decline year-over-year.
  • Astrana Health, Inc. annual Operating Income (Loss) for 2023 was $84.6M, a 18.8% decline from 2022.
  • Astrana Health, Inc. annual Operating Income (Loss) for 2022 was $104M, a 6.2% increase from 2021.
  • Astrana Health, Inc. annual Operating Income (Loss) for 2021 was $98.2M, a 22% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $95.4M $30.1M +$3.04M +11.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $92.4M $30.1M +$7.77M +34.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $84.6M -$3.87M -$16.5M -131% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $101M $39.1M -$11M -22% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $112M $27M +$11.6M +75.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $100M $22.4M -$3.84M -14.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $104M $12.6M +$10.3M +460% Oct 1, 2022 Dec 31, 2022 10-K/A 2023-08-09
Q3 2022 $93.9M $50.1M -$3.07M -5.77% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $97M $15.4M -$5.61M -26.7% Apr 1, 2022 Jun 30, 2022 10-K/A 2023-08-09
Q1 2022 $103M $26.2M +$4.43M +20.3% Jan 1, 2022 Mar 31, 2022 10-Q/A 2023-08-09
Q4 2021 $98.2M $2.25M -$23.6M -91.3% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-08-09
Q3 2021 $122M $53.2M +$15.8M +42.3% Jul 1, 2021 Sep 30, 2021 10-K/A 2023-08-09
Q2 2021 $106M $21M +$8.08M +62.6% Apr 1, 2021 Jun 30, 2021 10-K/A 2023-08-09
Q1 2021 $97.9M $21.8M +$17.4M +399% Jan 1, 2021 Mar 31, 2021 10-K/A 2023-08-09
Q4 2020 $80.5M $25.9M +$14.9M +137% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-15
Q3 2020 $65.6M $37.4M +$27.3M +271% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $38.3M $12.9M -$1.82M -12.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $40.1M $4.37M +$7.67M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $32.4M $10.9M +$8.93M +446% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 $23.5M $10.1M -$46.5M -82.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-15
Q2 2019 $70M $14.7M +$7.58M +106% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-15
Q1 2019 $62.4M -$3.31M -$26M -115% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-15
Q4 2018 $88.4M $2M +$7.85M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $80.6M $56.6M +$35.3M +166% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $45.3M $7.15M +$3.09M +76.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $42.2M $22.7M +$7.02M +44.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $35.1M -$5.84M -$4.17M -249% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $39.3M $21.3M +$23.4M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $15.9M $4.06M +$5.82M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $10.1M $15.7M +$19.4M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$9.34M -$1.68M -$216K -14.8% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-14
Q3 2016 -$9.13M -$2.17M -$1.76M -427% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$7.36M -$1.76M -$97.8K -5.87% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$7.27M -$3.73M -$3.89M -2356% Jan 1, 2016 Mar 31, 2016 10-K 2017-06-29
Q4 2015 -$3.37M -$1.46M +$72.1K +4.71% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$3.44M -$413K -$2.27M -122% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$1.17M -$1.66M -$478K -40.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$694K $165K +$712K Jan 1, 2015 Mar 31, 2015 10-K 2016-06-29
Q4 2014 -$1.41M -$1.53M -$723K -89.4% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-16
Q3 2014 -$684K $1.86M +$2.65M Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-11-17
Q2 2014 -$3.33M -$1.19M +$585K +33% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-28
Q1 2014 -$3.91M -$547K -$490K -852% Feb 1, 2014 Mar 31, 2014 10-K 2015-07-14
Q4 2013 -$3.42M -$809K -$284K -54% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-23
Q3 2013 -$3.14M -$787K +$651K +45.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$3.79M -$1.77M -$1.71M -2711% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$2.08M -$57.5K -$4.31K -8.11% Feb 1, 2013 Mar 31, 2013 10-QT 2014-07-08
Q4 2012 -$2.08M -$525K -$256K -95.4% Nov 1, 2012 Jan 31, 2013 10-K 2014-05-08
Q3 2012 -$1.82M -$1.44M -$1.56M -1239% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-20
Q2 2012 -$259K -$63K +$20.3K +24.4% May 1, 2012 Jul 31, 2012 10-K 2014-05-08
Q1 2012 -$279K -$53.2K +$134K +71.6% Feb 1, 2012 Apr 30, 2012 10-K 2014-05-08
Q4 2011 -$413K -$269K Nov 1, 2011 Jan 31, 2012 10-K 2013-05-01
Q3 2011 $126K +$130K Aug 1, 2011 Oct 31, 2011 10-K 2013-05-01
Q2 2011 -$83.3K -$64.8K -350% May 1, 2011 Jul 31, 2011 10-K 2013-05-01
Q1 2011 -$187K Feb 1, 2011 Apr 30, 2011 10-K 2013-05-01
Q3 2010 -$3.38K* Aug 1, 2010 Oct 31, 2010 10-Q/A 2012-04-10
Q2 2010 -$18.5K May 1, 2010 Jul 31, 2010 10-Q/A 2012-04-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.